Although Toll-like Receptors (TLRs) play a major function in innate recognition of pathogens, their role in antigen processing and presentation in vivo is poorly understood. Here we establish that Toxoplasma gondii profilin, a TLR11 ligand present in the parasite, is an immunodominant antigen in the CD4 + T cell response to the pathogen. The immunogenicity of profilin was entirely dependent on both TLR11 recognition and signaling through the adaptor myeloid differentiation factor 88 (MyD88). Selective responsiveness to this parasite protein was regulated at the level of antigen presentation by dendritic cells (DC) and required both TLR signaling and major histocompatibility complex (MHC) class II recognition acting in cis. These findings support a major influence of TLR recognition in antigen presentation by DC in vivo and establish a mechanism by which TLR ligand association regulates the immunogenicity of microbial antigens.
Introduction
Toll-like receptors (TLRs) are a major class of patternrecognition receptors involved in ''self'' versus ''nonself'' discrimination that play a major role in the initiation of the both innate and adaptive immunity to infectious agents (Takeda and Akira, 2005; Iwasaki and Medzhitov, 2004 ). To date, 12 different TLRs have been identified in mammals that recognize a number of distinct and highly conserved chemical structures (pathogen-associated molecular patterns, PAMP) present on nucleic acids, carbohydrates, lipids, and proteins of microbial agents O'Neill, 2006) . Upon recognition of their ligands, TLRs transduce signals through two pathways involving distinct adaptor proteins containing Toll/ IL-1R (TIR) domains (O'Neill et al., 2003) . One of these adaptors, MyD88, is utilized by all of the known TLRs except TLR3, which instead signals through the TIR domain-containing adaptor inducing IFN-b (TRIF) , also known as TIR domain-containing adaptor molecule 1 (TICAM-1) (Yamamoto et al., 2002; Oshiumi et al., 2003; Hoebe et al., 2003) . TLR4, the receptor for LPS, is unique in its capacity to signal through either of the two adaptors (Yamamoto et al., 2003) . The end product of TLR signaling is the nuclear factor-kB (NF-kB)-dependent induc-tion of proinflammatory cytokines and costimulatory molecules required for immune response initiation.
Dendritic cells (DC) are important mediators of TLR interaction with microbial ligands (Iwasaki and Medzhitov, 2004) . These major sentinels of the immune system transport foreign antigens from the periphery to lymphoid organs where they initiate T cell responses (Banchereau and Steinman, 1998) . In order to do so, DC must first be activated through TLR encounter with PAMP, resulting in the induction of inflammatory cytokines as well as migration to secondary lymphoid organs . Recent in vitro data suggest that TLR ligand interaction in DC also directly affects the process of antigen (Ag) presentation itself Medzhitov, 2004, 2006; West et al., 2004) . Thus, in the absence of MyD88 signaling or specific TLR, DC show impaired uptake of bacteria or LPS-coated beads and subsequent stimulation of CD4 + T cells (Blander and Medzhitov, 2004) . Nevertheless, these findings have been difficult to generalize to other systems, and their possible relevance in regulating T cell activation in vivo has never been formally addressed.
In the present study we have examined the role of TLR recognition in governing the CD4 + T cell response to a pathogen-derived protein from the protozoan parasite Toxoplasma gondii. This molecule, T. gondii profilin, was recently identified by us as a TLR11 ligand that selectively activates DC belonging to the CD8a + subset for the production of Interleukin-12 (IL-12) and other cytokines by means of an MyD88-dependent pathway (Yarovinsky et al., 2005; Yarovinsky and Sher, 2006) . We demonstrate here that although previously characterized as a minor component in the parasite, profilin is an immunodominant protein in the CD4 + T cell response to a soluble extract of the tachyzoite stage of the parasite (STAg) as well as to live T. gondii infection. We further show that the immunodominance of profilin depends on TLR11 and MyD88 both in vivo and in vitro and appears to result from the enhanced and selective uptake of the protein by CD8a + DC expressing this signaling pathway. Taken together, our findings suggest that physical association with TLR ligands can play a major role in promoting CD4 + T cell responsiveness to protein Ag and, in the case of pathogens, may be an important factor determining the selective immunogenicity of microbial components.
Results
CD4 + T Cells from Mice Immunized with a Complex Parasite Extract Selectively Recognize T. gondii Profilin It has been previously established that CD4 + T lymphocytes are rapidly activated in response to T. gondii infection and that they are necessary for host resistance to the pathogen (Suzuki and Remington, 1988; Gazzinelli et al., 1991; Araujo, 1991) . We predicted that because of its dual property as a protein Ag and TLR receptor agonist that potently stimulates DC, T. gondii profilin might *Correspondence: fyarovinsky@niaid.nih.gov be highly immunogenic and provide a better stimulus for CD4 + T cell responses than other Ag in the parasite. To test this hypothesis, we employed a previously established protocol (Jankovic et al., 2002) mimicking T. gondii infection in which mice are repeatedly immunized with an unfractionated soluble extract of the tachyzoite stage of the parasite (STAg) containing a complex mixture of microbial components (Yarovinsky et al., 2005) . This procedure results in the induction of strong parasite-specific CD4 + T cell response comparable to those observed in infected animals (Jankovic et al., 2002) . At 7 days after the last STAg injection, purified CD4 + T cells from mice primed in this manner were assessed for their recall proliferative responses to STAg versus recombinant profilin via irradiated splenocytes from unimmunized animals as antigen-presenting cells (APC). We found that on a weight per weight basis, purified profilin stimulated as much if not more proliferation than the unfractionated parasite extract ( Figure 1A ) in recall assays, suggesting that although it is a minor component in the pathogen (Yarovinsky et al., 2005) , this protein is a dominant Ag in the CD4 + T cell response elucidated by T. gondii. Importantly, no measurable recall response was observed to a second recombinant protein Cyclophilin-18, a parasite molecule previously identified in STAg that functions as a CC chemokine receptor 5 (CCR5) rather than TLR ligand (Aliberti et al., 2003) . Similar results were obtained when IFN-g production was measured as a read-out of CD4 + T cell reactivity (Figure 1B) . The observed immunodominance of profilin could not be explained by possible endotoxin contamination of either the recombinant protein or STAg, since the same response pattern was observed in STAgimmunized TLR4-deficient mice (see Figure S1 in the Supplemental Data available online).
The Immunogenicity of Profilin Depends on Host TLR11 Expression
To determine whether the unusual CD4 + T cell stimulatory capacity of profilin stems from its property as a TLR11 ligand, we compared recall responses to profilin and STAg in parasite extract-immunized Tlr11 2/2 versus WT mice, in each case using WT splenocytes as APC. Strikingly, we found that profilin failed to elicit a substantial recall response in the TLR11-deficient animals and that in addition, the response to STAg was also greatly diminished in these mice versus similarly immunized WT mice ( Figure 1C versus Figure 1A ). Further analysis revealed that CD4 + T cell activation as measured by CD44 expression was substantially reduced in STAgimmunized Tlr11 2/2 versus WT control animals (Figure 1D) . The latter observation raised the possibility that the nonresponsiveness of Tlr11 2/2 mice to profilin stems from a generalized abrogation of APC cytokine and costimulatory signals resulting from the absence of the major TLR signal associated with the parasite extract (Yarovinsky et al., 2005) . To test this hypothesis, we asked whether the inclusion of either LPS ( Figure 1E ) or complete Freund's adjuvant (data not shown) in the STAg immunization protocol would rescue the profilin response. We found that while addition of either of these TLR stimuli corrected the defect in CD4 + T cell activation in the immunized TLR11-deficient mice ( Figure 1F ), neither stimulus restored the dose-dependent CD4 + T cell recall response to purified profilin ( Figure 1E and data not shown).
We next asked whether TLR11 governs the response to profilin during natural infection with T. gondii. To do so, WT and Tlr11 2/2 mice were inoculated with the ME49 parasite strain, and 2 weeks postinfection, spleen cells were restimulated with either STAg or recombinant profilin, and IFN-g-producing CD4 + T cells were quantitated by intracellular cytokine staining and flow cytometry. As shown in Figure 1G , infected WT mice mounted strong recall responses to both STAg and profilin. Consistent with the results obtained with STAg immunization ( Figure 1C ), the response to profilin (as well as to STAg itself) was found to be greatly diminished in the infected Tlr11 2/2 animals.
The Immunogenicity of T. gondii Profilin Depends on Signaling through MyD88
To determine whether TLR11 governs the selective immunogenicity of profilin by simply promoting interaction of the antigen with APC or whether immunogenicity of profilin also requires signal transduction, we analyzed the response of Myd88 2/2 mice to either STAg or profilin immunization. As shown in Figure 1H , STAg-immunized Myd88 2/2 mice failed to mount a detectable recall response to profilin and displayed a diminished response to the parasite extract itself, findings that closely mirrored those obtained with Tlr11 2/2 mice ( Figure 1C ).
Taken together, the above data indicated that the immunodominance of profilin depends on both its recognition by TLR11 and on the generation of an MyD88dependent signal.
The Immunogenicity of Profilin Depends on Dual Expression of MyD88 and MHC Class II Molecules in the Same Bone Marrow-Derived Cell Population
Although the CD4 + T cell response to profilin was greatly impaired in MyD88-deficient mice, it was possible that this defect is due to a generalized lack of TLR-induced cytokine production in vivo . To address whether MyD88 expression is required within antigen-presenting cells, bone marrow chimera experiments were performed involving WT recipients reconstituted with a 1:1 mixture of H2-Ab1 2/2 (MHC class II-deficient) and Myd88 2/2 BM cells ( Figure 2 ). As expected, chimeras reconstituted with WT or MHC class II-deficient BM cells and injected with STAg produced high amounts of serum IL-12 measured at 6 hr whereas the chimera reconstituted with Myd88 2/2 BM failed to respond. Also as expected, chimeras reconstituted with a mixture of Myd88 2/2 and MHC class II-deficient BM cells mounted a vigorous cytokine response (Figure 2A ). CD4 + T cell recall responses to profilin were then analyzed by intracellular IFN-g staining in the same animals after repeated immunization with STAg as described above. As indicated in Figures 2B and 2C , the mixed chimeras reconstituted with both Myd88 2/2 and MHC class II-deficient BM displayed greatly diminished CD4 + T cell IFN-g responses to STAg or profilin in comparison with the control WT into WT chimeras despite their unimpaired IL-12 production ( Figure 2A ). This reduction in IFN-g + CD4 + T cells was not due to their conversion into an IL-4-positive (Th2) population ( Figures 2B and 2C ). Similar results were obtained when proliferative responses were assayed in the same cultures (data not shown). The above observations argued that the unusual immunogenicity of profilin depends on the dual expression of MyD88 and MHC class II on the same BM-derived cell population and is not simply the result of the potent systemic TLR-dependent cytokine response triggered by the protein. (D) Spleen cells from the same naive and immunized mice shown in (A) and (C) were stained for both CD4 and CD44. The histograms show CD44 staining gated on CD4 + T cells from naive WT mice (shadow), WT mice immunized with STAg (bold line), and Tlr11 2/2 mice immunized with STAg (thin line). (E) Tlr11 2/2 animals were immunized as described above with STAg but in this case with the inclusion of LPS (10 mg/mouse). Recall responses were measured against STAg (filled circles) or profilin (open circles) also as above. (F) CD44 staining gated on CD4 + T cells from naive WT mice (shadow), WT mice immunized with STAg+LPS (bold line), or Tlr11 2/2 mice immunized with STAg+LPS (thin line). (G) WT and Tlr11 2/2 mice were infected i.p. with 20 cysts of the Me49 T. gondii strain. 14 days later, spleen cells from these animals were restimulated in vitro with 10 mg/ml of either STAg or profilin and IFN-g-secreting CD4 + T cells quantitated in the cultures by intracellular staining. (H) WT (circles) or Myd88 2/2 (triangles) animals were repeatedly immunized with STAg, and CD4 + T cell responses to either STAg (filled symbols) or profilin (open symbols) were analyzed by the protocol described above. The experiments shown are representative of 3-5 performed, each involving pooled spleens from at least three mice per group. The proliferation values are means 6 standard deviation (SD) of H 3 -thymidine incorporation counts from duplicate or triplicate cultures.
Antigen Presentation of Profilin by DC Is MyD88
Dependent and Limited to the CD8a + Subset To characterize the MyD88-dependent cell population required for the immunogenicity of profilin, ex vivo experiments were performed in which splenic APC from STAg-injected mice were used to stimulate a pool of different profilin-specific CD4 + T cell clones. Initial experiments (data not shown) indicated that only the CD11c + spleen cell fraction was able to trigger proliferation of these T lymphocytes. Interestingly, in kinetic experiments, peak antigen presentation by the CD11c + population was observed at 6 hr postinjection ( Figure 3A) , a time corresponding to that previously described as the period of maximal IL-12 production by DC after STAg injection (Reis e Sousa et al., 1997; Schulz et al., 2000) . Similarly, as reported previously for DC IL-12 production, the antigen-presentation function of DC primed in vivo by STAg was restricted to the CD8a + subset (Figures 3B and 3C) . Despite their similar requirements, STAg-induced IL-12 production and profilin-specific antigen presentation were shown to be independent functions since DC from IL-12p40-deficient mice showed unimpaired APC function in our assay (Figures 3D and 3E) . Importantly, DC stimulation of profilin-specific CD4 + T cells in common with in vivo responsiveness to the same antigen was strictly dependent on both MyD88 and TLR11 ( Figures 3F and 3G ), arguing that TLR regulation of this response occurs primarily at the level of CD8a + DC.
To determine whether the combined TLR11 and MyD88 requirement for profilin presentation is due merely to a necessity for DC maturation or migration, we attempted to rescue the response by coinjecting MyD88-deficient animals with LPS in addition to STAg. Consistent with previous findings, the inclusion of LPS resulted in both the migration and recruitment of splenic DC presumably through the MyD88-independent TRIF pathway  and data not shown). Nevertheless, the DC from these coinjected animals failed to stimulate profilin-specific CD4 + T cells, arguing that the requirement for TLR11 in antigen presentation occurs at the level of DC recognition of the protein and is not due solely to its function in DC activation ( Figure S2 ).
The requirements for TLR11 and MyD88 in presentation of profilin to CD4 + T cells were also evident when mice were infected with live tachyzoites (the rapidly growing stage of the T. gondii parasite). While CD8a + splenic DC recovered from WT mice 6 hr after parasite inoculation potently stimulated proliferation of profilinspecific CD4 + T cells, DC from similarly infected MyD88-or TLR-deficient animals were highly defective in promoting this response ( Figure S3 )
The Role of MyD88 in Profilin-Induced CD4 + T Cell Responses Is DC Intrinsic To further address the role of MyD88 signaling in the stimulation of CD4 + T cell responses by profilin-primed DC, we asked whether this requirement is intrinsic to the APC itself or depends on the expression of the adaptor molecule in unrelated cells in the host environment. To do so, we prepared mixed chimeric animals in which WT mice were reconstituted with a 1:1 ratio of WT and MyD88-deficient BM cells expressing either CD45.1 or CD45.2, respectively. These, as well as control chimeras, were then injected with STAg and the spleens recovered 6 hr later and separated into CD11c + populations of Myd88 2/2 and WT origin by means of the presence of the appropriate CD45 allelic markers ( Figures 4A-4C ). The sorted DC populations were then tested for their ability to stimulate profilin-specific CD4 + T cells. WT (MyD88 + CD45.1 + ) DC isolated from mice reconstituted Irradiated C57BL/6 mice were reconstituted with BM cells from WT, Myd88 2/2 , H2-Ab1 2/2 , or a 1:1 mixture of the latter two cell populations. 8 weeks later, the animals were repeatedly immunized with STAg as in previous experiments. (A) Serum IL-12p40 levels measured by ELISA 6 hr after the first STAg injection. Nonchimeric WT, TLR11-, and MyD88-deficient mice receiving the same treatment are shown as controls. Data shown are mean 6 SD of determinations on five animals per group. (B and C) Recall response to STAg (B) or profilin (C) assayed in the above animals at day 7 after the last immunization. The response was quantified by intracellular cytokine staining for IFN-g and IL-4 on day 3 poststimulation to assess whether changes in Th1 cytokine levels were reflected in enhanced Th2 activity. The results shown are representative of repeat experiments both performed with two independently derived sets of chimeras. either with WT BM alone or the mixture of WT and Myd88 2/2 BM cells induced potent CD4 + T cell proliferation ( Figure 4D ). In contrast, Myd88 2/2 CD45.1 2 DCs recovered from either the mixed chimera or a control chimera reconstituted with MyD88-deficient BM cells alone failed to stimulate significant CD4 + T cells responses ( Figure 4D) . These results confirmed that the requirement for MyD88 in DC priming by profilin is cell intrinsic and is not the result of indirect maturation signals dependent on this adaptor molecule.
In Vitro Stimulation of Profilin-Specific CD4 + T Cells Is Partially Dependent on TLR11 and MyD88 Expression in DC We next addressed whether the same requirement for TLR signaling in activation of profilin-specific CD4 + T cell responses that we observed in vivo also occurs with isolated DC directly exposed to the protein in vitro in the absence of other interacting cell populations. To do so, we sort-purified splenic DC from naive WT, Myd88 2/2 , or Tlr11 2/2 mice and cocultured them with profilin-specific T cells in the presence of increasing concentrations of STAg or profilin. Proliferative responses were then measured 72 hr later. As expected, both antigen preparations induced potent responses in the cultures containing WT DC. In contrast, at most doses tested, reduced proliferation was observed in cultures containing Myd88 2/2 or Tlr11 2/2 DC ( Figure S4 ). Nevertheless, this dependency on both MyD88 and TLR11 was overcome at high antigen concentration, suggesting that while TLR signaling facilitates triggering of profilin-specific CD4 + T cells, it is not a mandatory requirement.
MyD88/TLR11 Regulates Uptake of Profilin by DC In Vivo The above data indicated that MyD88-and TLR11dependent presentation of profilin is dose dependent and therefore may reflect a role of TLR in Ag uptake by DC distinct from their function in DC maturation. This hypothesis is also compatible with the more pronounced affects of TLR11 signaling in regulating profilin responses in vivo as opposed to in vitro, since Ag concentration is more limiting in the former situation. To assess the role of enhanced Ag uptake as an explanation of the data, we injected mice with fluorescent-labeled profilin (Alexa 488-profilin) and examined its incorporation by both CD8a + and CD8a 2 CD11c + DC and then assessed the ability of Alexa 488 + versus Alexa 488 2 DC to activate profilin-specific CD4 + T cells. The Alexa 488-profilin conjugate was confirmed to be fully active in its ability to trigger TLR11-dependent cytokine production ( Figure S5 ). As shown in Figure 5A , uptake of the labeled Ag was observed in WT CD8a + , but not in CD8a 2 DC. Moreover, in the former population, DC from WT animals showed a greater than 5-fold increase in Alexa 488 + cells compared with either MyD88-or TLR11-deficient DC, with the latter displaying no substantial enhancement in fluorescence with respect to cells from uninjected mice. Consistent with these observations, Alexa 488 + CD8a + DC from WT mice were the most effective of any of the Alexa 488 + or Alexa 488 2 DC populations tested in terms of their ability to stimulate profilin-specific CD4 + T cells ( Figure 5B ).
Fusion of Profilin or CpG with Ovalbumin Results in Markedly Enhanced OVA-Specific CD4 + T Cell Priming
The results presented above demonstrated that TLR recognition and MyD88-dependent signaling regulate the CD4 + T cell response to T. gondii profilin. Nevertheless, most TLRs recognize chemical structures that are C57BL/6 mice (3 per group) were i.p. injected with 10 mg of STAg or PBS (empty bars), and spleen cells were recovered and pooled from these animals at 6 hr (gray bars), 24 hr (dark gray bars), and 48 hr (black bars) after antigen inoculation. (A-C) Bulk CD11c + (A) as well as CD11c + CD8a + (B) or CD11c + CD8a 2 (C) DC were then purified from these samples and incubated with a mixture of profilin-specific CD4 + T cell clones for 72 hr. T lymphocyte proliferation was then measured by H 3 -thymidine incorporation. (D and E) The experiment shown is representative of three performed CD8a + (D) and CD8a 2 (E) DC were sort-purified from WT (black bars) or IL-12p40-deficient animals (white bars) 6 hr post STAg inoculation and tested for their ability to stimulate profilinspecific CD4 + T cells as above. (F and G) CD8a + (F) and CD8a 2 (G) DC from WT (black bars), MyD88deficient animals (white bars), or Tlr11 2/2 (gray bars) were sortpurified 6 hr post STAg inoculation and tested as above. The experiments shown in (D)-(G) involved DC recovered and pooled from three mice per group and are representative of at least two experiments performed. The data shown are the mean 6 SD. nonpeptidic and thus would not be expected to be directly associated with protein epitopes during antigen processing and presentation. To test whether association with nonprotein TLR ligands can regulate antigen priming of CD4 + T cells, we compared the immunogenicity of ovalbumin (OVA) alone, or OVA admixed with a TLR9 agonist (immunostimulatory sequences, 1018 ISS) with that of the same protein antigen chemically conjugated with ISS (Hemmi et al., 2000; Cho et al., 2000) . As expected, addition of 1018 ISS to OVA resulted in a significant CD4 + T cell response to the protein as measured by proliferative recall response ( Figure 6A ). Importantly, immunization with the same amount of protein directly conjugated to the ISS TLR9 ligand led to a dramatically increased CD4 + T cell response to the antigen, and this enhancement (as well as that induced by admixing of the ISS) was not observed when MyD88-or TLR9deficient mice were immunized in the same experiment ( Figure 6B ). Moreover, no responses were detected when a nonstimulatory ISS (1040 ISS) was substituted for the immunostimulatory oligonucleotide in the protocol ( Figure 6A ). The above findings directly demonstrate the enhancing effects of TLR ligand linkage to protein in promoting CD4 + T cell priming.
To further test the hypothesis that physical association of TLR ligands with protein Ag promotes CD4 + T cell priming, we asked whether covalent association of profilin to OVA would result in augmented OVA-specific CD4 + T cell responses to the latter antigen as a consequence of the TLR11 agonist activity of the parasite protein. To do so, we constructed a recombinant Profilin-OVA fusion protein. Fusion with OVA did not impair the TLR11-dependent IL-12-inducing activity of the profilin molecule ( Figure S5) . Moreover, the profilin-OVA fusion protein retained its profilin-specific immunogenicity inducing CD4 + T cell responses at a level comparable to that stimulated by an equivalent amount of unmodified profilin or profilin admixed at a 1:1 ratio with OVA (Figure 6C) . When tested for its ability to trigger OVA-specific T cell responses, the profilin OVA fusion profilin was found to be highly immunogenic, inducing strong recall proliferative responses not seen in mice injected with either OVA alone or OVA admixed with profilin ( Figure 6D ). Importantly, this enhanced immunogenicity was dependent on TLR11 signaling ( Figure 6D ).
Taken together, the above findings demonstrated that covalent association of TLR ligands with protein Ag markedly enhances their induction of CD4 + T cell responses, thereby providing an explanation for the immunodominance of T. gondii profilin.
Discussion
The results presented here identify a function for TLR signaling in regulating the immunogenicity of pathogen-associated protein antigens and elucidate a pathway through which innate recognition can influence the adaptive immune response. We observed that TLR11 recognition of T. gondii profilin renders this molecule into a highly immunodominant Ag in the CD4 + T cell response to the parasite, a property that appears to stem from the enhanced uptake and presentation of the protein as a consequence of its activity as a TLR ligand.
Proteins generally are not targets for TLR recognition. Bacterial flagellin and apicomplexan profilins are the only well-defined examples of nonself proteins seen by the TLR system (Hayashi et al., 2001; Yarovinsky et al., 2005) . Both molecules are also microbial antigens, and previous studies with flagellin, which is recognized by TLR5, have indicated that this protein is an immunodominant Ag in the CD4 + T cell response to Salmonella typhimurium (Cookson and Bevan, 1997; McSorley et al., 2000) , and large numbers of flagellin-specific CD4 + T cells can be recovered from animals with chronic intestinal inflammation presumably as a result of sensitization by gut flora (Lodes et al., 2004) . In the present study, we observed that profilin, recognized by TLR11, displays a similar immunodominance in the response to T. gondii and formally demonstrated that this property depends on TLR recognition and signaling at the level of the same APC that is presenting the antigen. The latter contention is based on the evidence that in (A-C) Irradiated C57BL/6.SJL (CD45.1 + ) mice were reconstituted with WT (CD45.1 + ) (A), Myd88 2/2 (CD45.1 2 ) (B), or a mixture of WT and MyD88deficient (C) BM cells. 8 weeks later, the animals were injected with STAg (10 mg) and CD11c + CD45.1 + (WT) and CD11c + CD45.1 2 (Myd88 2/2 ) were sort-purified from spleens as shown in density plots. (D) The different DC populations were then tested for their ability to stimulate profilin-specific CD4 + T cell proliferation. The populations studied and their respective flow-cytometric profile were as follows: WT/WT reconstitution (gray bars, quadrant 1); Myd88 2/2 /WT reconstitution (white bars-panel, quadrant 2); WT+ Myd88 2/2 /WT reconstitution (black bars, WT DC; hatched bars, MyD88-deficient DCs; quadrant 3 and 4, respectively). The data shown are the mean 6 SD, the results are representative of two independent chimera experiments performed, each involving at least six animals per group of which spleens from three mice were pooled for cell separation.
WT+Myd88 2/2 chimeric animals, only the WT DC are able to activate profilin-specific CD4 + T cells and that in MHC class II-deficient chimeras, priming of CD4 + T lymphocytes with the same specificity depends on joint expression of MyD88 and MHC class II in the same APC compartment. Furthermore, nonspecific maturation signals delivered by a heterologous TLR ligand in themselves failed to render profilin into an immunogenic molecule. These data argue that the TLR11 signal delivered by profilin influences its processing and presentation by DC in a cis fashion within the same DC. We speculate that this mechanism may also account for the previously described immunodominance of the TLR5 ligand containing protein flagellin.
A role for TLR signaling in the regulation of Ag processing and presentation has been suggested in several previous reports involving in vitro culture of DC with TLR2 or TLR4 stimuli. In one of these studies, LPS stimulation was shown to induce a rapid but transient enhancement of the uptake of FITC-labeled dextran by these cells (West et al., 2004) . More relevant to the work presented here was the demonstration by Blander and Medzhitov that MyD88-dependent TLR recognition promotes the phagocytosis of Gram-negative or Grampositive bacteria (or particles covered with LPS or PGN, respectively) while inducing phagosome maturation (Blander and Medzhitov, 2004) . In a subsequent study (Blander and Medzhitov, 2006) , it was shown that TLR recognition regulates the ability of DC to present experimental Ag to CD4 + T cells after phagocytosis of E. coli. Our findings extend these earlier observations by demonstrating that TLR signaling can directly promote the ability of APC to take up and present soluble protein Ag to CD4 + T cells in vivo and that this effect depends on the physical association between the TLR ligand and the protein in question.
Multiple mechanisms are likely to regulate CD4 + T cell activation by profilin primed DC in vivo. Our studies on DC interaction with profilin reveal that TLR11-and MyD88-expressing DC have an enhanced capacity to WT, Myd88 2/2 , or Tlr11 2/2 mice (three per group) were injected i.p. with 10 mg of Alexa 488-profilin, and 6 hr later the animals were sacrificed and spleens cells prepared and pooled for each group. The cells were then stained with CD11c-APC and CD8a-PE and analyzed for each of the latter fluorochromes as well as Alexa 488. (A) The results shown are histograms of Alexa 488 staining gated on either the CD8a + (PE + ) or CD8a 2 (PE 2 ) CD11c + cell populations. The horizontal bars indicate the percentage of Alexa 488 + cells for each analysis based on comparison with the background staining patter observed with cells prepared from the uninjected WT animals. (B) Ability of Alexa 488 2 CD8a + (fluorescence intensity < 10 3 ) and Alexa 488 + CD8a + (fluorescence intensity R 10 3 ) cell populations identified in (A) to stimulate profilin-specific CD4 + cells as described in previous figures. The experiment shown is representative of three performed. incorporate the protein when compared with DC lacking these TLR components. We speculate based on these results that TLR11, in addition to the promoting the physical binding of this Ag to DC, may initiate MyD88dependent signals that regulate Ag internalization and/ or retention. Coupled together with TLR-dependent triggering of DC maturation (Reis e Sousa et al., 1997; Schulz et al., 2000; Yarovinsky et al., 2005) , these effects would lead to a major influence of the MyD88-dependent TLR pathways on presentation of profilin or other Ag that incorporate TLR ligands. It is important to note, however, that the TLR requirement defined here is not absolute and, as demonstrated in our in vitro experiments, can be overcome at high Ag concentration. Nevertheless, in the in vivo setting, where Ag levels are in most cases limiting (Catron et al., 2004) , the observed role of TLR in Ag presentation of TLR ligand-associated Ag should be pronounced, consistent with the findings on profilin responses described above.
The concept that association with TLR ligands increases protein immunogenicity is supported in the literature by several studies in which chemical coupling of either TLR9, TLR7, or TLR8 agonists to either vaccine target or model Ag was shown to result in amplified CD8 + or Th1 cell responses (Cho et al., 2000; Shirota et al., 2001; Hayashi et al., 2003; Wille-Reece et al., 2005) . That this enhancement can operate at the level of TLR-dependent Ag presentation to CD4 + T cells is demonstrated by the data shown here in which conjugation of OVA with CpG or fused expression with profilin was shown to result in a marked elevations in in vivo CD4 + T cell responses to the protein that were regulated in an MyD88-dependent fashion by TLR9 or TLR11, respectively. Again, it is important to note that in both instances, the observed increases in immunogenicity were not seen when TLR ligand was admixed rather than directly linked to this protein Ag. Although not formally demonstrated here, we speculate that the latter requirement reflects a role for TLR in Ag internalization in addition to the stimulation of APC maturation as suggested by our in vivo experiments with unmodified profilin.
An important issue raised by the findings on profilin immunogenicity presented here concerns the function of TLR ligand association in determining the immunodominance of specific CD4 + T cell responses against pathogens during infection. In addition to the example of bacterial flagellin discussed above, other microbial Ag may incorporate TLR ligands as part of their structure. For instance, the lipid moieties of pathogen-derived lipoproteins can serve as TLR2 agonists , and a number of different microbial lipoproteins have been demonstrated to be highly immunogenic (Ghielmetti et al., 2005) . Further work is needed to determine whether these molecules represent immunodominant Ag in the response to the pathogens from which they are derived and, if so, whether the observed immunogenicity is TLR and MyD88 dependent. If indeed our observations on the role of TLR signaling in the CD4 + T cell response to T. gondii profilin can be further generalized to other TLR ligand-associated microbial Ag, this mechanism may deserve consideration as an important factor biasing the specificity of the T cell repertoire directed against pathogens and as a strategy exploited by either host or pathogen in promoting the outcome of infection.
Experimental Procedures
Animals C57BL/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME). Myd88 2/2 and Tlr4 2/2 mice on a C57BL/6 background were generously provided by Dr. S. Akira (Osaka University, Japan). TLR11-deficient animals on a mixed C57BL/6x129 background were kindly provided by Drs. S. Ghosh and D. Zhang (Yale University, New Haven, CT). WT (Tlr11 +/+ or Tlr11 +/2 ) littermates from the same breeding stock gave responses to T. gondii profilin and STAg that were indistinguishable from those of C57BL/6 mice in the major experiments shown. C57BL/6.SJL (CD45.1 + ), H2-Ab1 2/2 , and IL-12p40-deficient mice were obtained from the National Institute of Allergy and Infectious Diseases (NIAID) Animal Supply Contract at Taconic Farms (Germantown, NY). All animals were maintained at an American Association of Laboratory Animal Care-accredited NIAID animal facility, and 8-to 12-week-old female mice were employed in all experiments. To generate bone marrow chimeric animals, mice were exposed to 950 RADs in a GammaCell 40 cesium irradiator and reconstituted on the same day with 1 3 10 6 bone marrow cells from the donor mouse strain(s). The animals were then (D) WT and Tlr11 2/2 mice were injected with either Profilin-OVA fusion protein, OVA mixed with profilin, or OVA alone. CD4 + T cell responses to titrated doses of OVA fragment (311-348) containing the OT-II CD4 + T epitope were then assayed as in (A)-(C) above. In preliminary studies, s.c. injection of CpG and i.p injection of profilin were found to be the optimal routes for immunization. The experiments shown are representative of three performed. maintained on acidified water for 4 wk and used in experiments 2-4 weeks later.
Parasite Antigens and Immunological Reagents STAg (soluble tachyzoite antigen) was prepared from tissue-culturederived tachyzoites of the RH88 strain as previously described (Reis e Sousa et al., 1997) . Recombinant T. gondii profilin was generated and purified as outlined previously (Yarovinsky et al., 2005) . Ovalbumin fraction VI (Sigma, cat #A2512) and LPS 0111:B4 (Sigma, cat # L-3024) were purchased from Sigma (St. Louis, MO). 1018 ISS and 1040 ISS were synthesized and conjugated with OVA by a coupling procedure described elsewhere (Cho et al., 2000) . OVA-profilin fusion protein was generated by inserting the OVA311-348 fragment (containing the OT-II CD4 + T cell epitope) in-frame with profilin via an XhoI restriction site located at the N terminus of the profilin gene and cloning the resulting construct into pET-14b vector (Novagen). The recombinant Profilin-OVA fusion was then expressed in BL21DE3pLys E. coli by the same protocol employed in the expression of the unmodified profilin gene. Alexa 488-labeled profilin was prepared by reacting the purified protein with the fluorochrome and purifying the product with a commercial kit from Invitrogen (Carlsbad, CA). Flourescein isothiocyanate (FITC)-labeled CD8a, CD11b, B220, and CD45.1 and phycoerythrin (PE)-labeled CD11c monoclonal antibodies were purchased from BD Biosciences (San Diego, CA).
In Vivo Immunization with Protein Antigens
To generate T. gondii-specific CD4 + T cell responses, WT or genetargeted mice were injected i.p. with STAg (10 mg per animal) 5 times at 4 day intervals as previously described (Jankovic et al., 2002) and utilized in experiments at 7-10 days after the last immunization. The effect of profilin fusion with OVA was assessed by immunizing mice by means of the same protocol with either OVA alone, OVA-profilin fusion protein, or OVA mixed with profilin (1:1 weight ratio) at a dose of 10 mg per injection. The effect of ISS (CpG oligonucleotides) conjugation on OVA-specific CD4 + T cell responses was determined by s.c. immunization with either OVA alone (25 mg), OVA conjugated with 1018 ISS (1018-OVA, 25 mg), OVA conjugated with control 1040 ISS (1040-OVA, 25 mg), or OVA (25 mg) admixed with 1018 ISS (25 mg) for each injection.
Toxoplasma gondii Infections
For studies of immune responses to live T. gondii infection, two different protocols were used. In the first, mice were inoculated i.p. with an average of 20 tissue cysts of the avirulent Me49 strain prepared from brain as described previously (Yarovinsky et al., 2005) . In the second procedure, mice were injected i.p. with 10 7 tachyzoites (RH88 strain) from infected human fibroblast cultures.
Ex Vivo Measurement of Antigen-Specific CD4 + T Cell Responses
To assay the response of animals immunized with the above antigen preparations or infected with T. gondii, spleens (or in the case of ISS/ OVA-injected animals, inguinal lymph nodes) were harvested from mice and pooled for each experimental group. The CD4 + populations were then purified by cell sorting (FACSVantage SE, BD Biosciences), and aliquots (10 5 cells each) were then mixed at a 1:4 ratio with irradiated WT splenocytes (as a source of APC) in 96-well Ubottom plates. After addition of the indicated amounts of antigen, the cultures were incubated for 48 hr and H 3 thymidine (1 mCi) was added to each well. Incorporation of the isotope was then determined after an additional overnight incubation. The data shown are the means of duplicate or triplicate cultures.
Profilin-Specific CD4 + T Cells
Profilin-specific CD4 + T cells were generated from C57BL/6 mice immunized repeatedly with STAg (Jankovic et al., 2002) as in Figure 1 . In brief, FACS-purified CD4 + T lymphocytes restimulated with STAg were cloned by limiting dilution and maintained in long-term culture as previously described (Jankovic et al., 2000) . Pools containing equal numbers of five different profilin-specific CD4 + T cell clones (identified by their response to the recombinant protein [Yarovinsky et al., 2005] ) were used to assess the ability of APC populations to present profilin.
Dendritic Cell Isolation
Dendritic cells were isolated from pooled (R3) spleens of naive mice or animals injected 6 hr, 24 hr, or 48 hr previously with 10 mg of STAg or 6 hr previously with live tachyzoites. For purification, single-cell suspensions were incubated on ice for 15 min with either CD11c-PE alone or a combination of CD11c and FITC-labeled CD8a-FITC or CD45.1 antibodies. The cells were then washed and sorted on a FACSVantage SE (BD Biosciences) as described previously (Yarovinsky et al., 2005) . In one set of experiments, the CD11c + CD8a + -Alexa 488 + and CD11c + CD8a + Alexa 488 2 cells were sort-purified from animals injected 6 hr previously with 1 mg of Alexa 488-labeled profilin alone (APC-labeled CD11c and PE-labeled CD8a antibodies were used for staining in this procedure rather than FITC conjugates).
Assay of CD4 + T Cell Stimulatory Activity of DC
To measure the capacity of DC to activate profilin-specific CD4 + T lymphocytes, the purified cell populations described above were cocultured with profilin-specific CD4 + T cells at the ratios indicated and proliferation measured H 3 thymidine incorporation. In one set of experiments CD8a + DC from naive WT, Tlr11 2/2 , or Myd88 2/2 mice were used to stimulate profilin-specific CD4 + T cells in the presence of different concentrations of exogenously added STAg or profilin.
Supplemental Data
Five Supplemental Figures can be found with this article online at http://www.immunity.com/cgi/content/full/25/4/655/DC1/.
